Report overview
Antiproliferative drugs are the type of immunosuppressive medication that works by blocking cell-cycle pathways, limiting the T- and B-cell proliferation and thereby lowering the cytotoxic response aimed at the cardiac allograft. It is also termed as antimetabolites. Immunosuppressants are a type of medication that helps to suppress the immune system's response to foreign substances. These medications limit the immune response and safeguard the new organ and its function, prevent organ rejection. They're most commonly used to prevent autoimmune illnesses such as arthritis, myasthenia gravis, Crohn's disease, lupus, rheumatoid arthritis, and organ transplant rejections like kidney, liver, and heart transplants.
This report contains market size and forecasts of Antiproliferative Drugs in Global, including the following market information:
Global Antiproliferative Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antiproliferative Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mycophenolate Mofetil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiproliferative Drugs include Accord Healthcare, F. Hoffmann-La Roche, Novartis AG, Mylan N.V., Astellas Pharma, Pfizer, Glenmark Pharmaceuticals Limited, Zydus Cadila and Bristol-Myers Squibb Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiproliferative Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiproliferative Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antiproliferative Drugs Market Segment Percentages, by Type, 2021 (%)
Mycophenolate Mofetil
Mycophenolate Sodium
Azathioprine
Global Antiproliferative Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antiproliferative Drugs Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Antiproliferative Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antiproliferative Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antiproliferative Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antiproliferative Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accord Healthcare
F. Hoffmann-La Roche
Novartis AG
Mylan N.V.
Astellas Pharma
Pfizer
Glenmark Pharmaceuticals Limited
Zydus Cadila
Bristol-Myers Squibb Company
GlaxoSmithKline
Sanofi
Allergan
AbbVie
Cipla
Johnson & Johnson Private Limited
Teva Pharmaceutical Industries
Veloxis Pharmaceuticals
Eli Lilly and Company
Lupin
AstraZeneca
